DNA Nanosponge for Adsorption and Clearance of Intracellular miR-21 and Enhanced Antitumor Chemotherapy
Source abstract
Abstract
Antisense oligonucleotide (ASO)-induced cellular signaling pathway alteration is evolving as a promising therapeutic strategy for improving antitumor chemotherapy. However, the inherent instability and inefficiency of ASO delivery remain major hurdles for its application. Herein, we developed a self-assembled DNA nanosponge (DNS) for adsorption and clearance of intracellular miR-21. The densely packed DNA nanostructure is able to provide large amounts of repeated ASO copies for efficient capturing of miR-21 and inhibiting the miRNAs function in mammalian cells. The cell apoptosis-related protein expression (Bcl-2, Bax, and cleaved caspase-3/9) can be obviously interrupted with the delivery of DNS. Besides, we have shown that the DNS can efficiently carry Dox for chemotherapy and inducing tumor cell (MCF-7) apoptosis meanwhile has little affect to normal cells (Hs578 Bst). These polymeric DNS systems mimic the natural RNA circle-based miRNA sponges and have potential to be applied for specific and efficient regulation of gene expression in tumor cells for synergistic antitumor chemotherapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · MicroRNA in disease regulation · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmaceutical Sciences, Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China
Funding
Zhengzhou University · Education Department of Henan Province · China Postdoctoral Science Foundation · Science and Technology Department of Henan Province · National Natural Science Foundation of China · Henan Province
References (32)
Show source-provided references
1. 10.1038/nrg137910.1038/nrg1379 ↗
2. 10.1038/nrc199710.1038/nrc1997 ↗
3. 10.1038/nrc184010.1038/nrc1840 ↗
4. 10.1038/nature0928410.1038/nature09284 ↗
5. 10.1073/pnas.120151610910.1073/pnas.1201516109 ↗
6. 10.1038/nature1199310.1038/nature11993 ↗
7. 10.1038/nrg.2016.2010.1038/nrg.2016.20 ↗
8. 10.1038/nature1192810.1038/nature11928 ↗
9. 10.1016/j.actbio.2015.07.02010.1016/j.actbio.2015.07.020 ↗
10. 10.1038/nmeth107910.1038/nmeth1079 ↗
11. 10.1038/nature1390510.1038/nature13905 ↗
12. 10.1039/c3cs60439j10.1039/c3cs60439j ↗
13. 10.1002/smll.201900172.10.1002/smll.201900172. ↗
14. 10.1002/anie.20180900610.1002/anie.201809006 ↗
15. 10.1039/C7SC02489D10.1039/C7SC02489D ↗
16. 10.1021/nn502596b10.1021/nn502596b ↗
17. 10.1016/j.biomaterials.2013.08.07910.1016/j.biomaterials.2013.08.079 ↗
18. 10.1038/am.2017.3410.1038/am.2017.34 ↗
19. 10.1038/nmat325310.1038/nmat3253 ↗
20. 10.1021/acsnano.9b0158910.1021/acsnano.9b01589 ↗
21. 10.1021/jacs.8b1079510.1021/jacs.8b10795 ↗
22. 10.1002/anie.20140032310.1002/anie.201400323 ↗
23. 10.1186/1471-2164-8-16610.1186/1471-2164-8-166 ↗
24. 10.1111/nyas.1295310.1111/nyas.12953 ↗
25. 10.1021/ja406115e10.1021/ja406115e ↗
26. 10.1021/ja903857f10.1021/ja903857f ↗
27. 10.1002/smll.20160399010.1002/smll.201603990 ↗
28. 10.1021/acsnano.8b0203410.1021/acsnano.8b02034 ↗
29. 10.1038/ncomms436410.1038/ncomms4364 ↗
30. 10.1073/pnas.090523410610.1073/pnas.0905234106 ↗
31. 10.1038/3516010.1038/35160 ↗
32. 10.1073/pnas.97.2.52910.1073/pnas.97.2.529 ↗